Harbor Advisory Corp MA Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Harbor Advisory Corp MA lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,816 shares of the financial services provider’s stock after selling 588 shares during the quarter. Harbor Advisory Corp MA’s holdings in iShares Biotechnology ETF were worth $1,562,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $30,000. HHM Wealth Advisors LLC boosted its stake in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Finally, Newbridge Financial Services Group Inc. bought a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4 %

NASDAQ:IBB opened at $134.24 on Wednesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business has a 50 day simple moving average of $135.99 and a 200-day simple moving average of $141.17.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.